最高の Targeted Talks ポッドキャスト (2024)

1
S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research 16:28

1d ago16:28

16:28

In this episode of Targeted Talks, Douglas Flora, MD, LSSBB, FACCC, executive medical director of oncology services at St. Elizabeth Healthcare, discusses the transformative impact of artificial intelligence in oncology.Targeted Talks による

1
S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander 27:56

16d ago27:56

27:56

In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.…

1
S5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology 16:20

1M ago16:20

16:20

Antonious Hazim, MD, hematology medical oncology fellow at Mayo Clinic, Rochester, Minnesota, shares insights on his journey into oncology, his experiences at the Mayo Clinic, and his ongoing research.Targeted Talks による

1
S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer 13:41

2M ago13:41

13:41

In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas Health Science Center San Antonio and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the background, fi…

1
S5 Ep16: Foran Goes Beyond the Basics of BPDCN 22:32

2M ago22:32

22:32

In this episode of Targeted Talks, James M. Foran, MD, discusses the presentation and diagnosis of blastic plasmacytoid dendritic cell neoplasm.Targeted Talks による

1
S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates 30:43

3M ago30:43

30:43

In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer Institute, discusses the latest developments in breast cancer research and treatment, focusing on the evolving understanding of HER2-low breast cancer subtypes and the potential advantages of…

1
S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel 16:05

3M ago16:05

16:05

In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.Targeted Talks による

1
S5 Ep13: Cancer Research Across Continents: Fujiwara’s Path From Japan to the US 19:23

4M ago19:23

19:23

In this episode of Emerging Experts, Yu Fujiwara, shares his journey from Japan to the United States and his path to becoming a specialist in hematology and oncology.Targeted Talks による

1
S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role 18:04

4M ago18:04

18:04

In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma.Targeted Talks による

1
S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine 23:58

5M ago23:58

23:58

Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.Targeted Talks による

1
S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM 20:11

5M ago20:11

20:11

In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma.Targeted Talks による

1
S5 Ep9: Unlocking the Potential of Technology in Community Oncology 25:49

6M ago25:49

25:49

In this episode of Targeted Talks, Nini Wu, MD, MBA, chief medical and development officer at Cardinal Health, shares her insights on the ever-changing world of technology in the community oncology setting.Targeted Talks による

1
S5 Ep8: LaPelusa’s Journey in the Dynamic Field of GI Oncology 14:20

7M ago14:20

14:20

In the latest episode of Emerging Experts, Michael LaPelusa, MD, hematology and oncology fellow at MD Anderson Cancer Center, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.Targeted Talks による

1
S5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches 26:53

7M ago26:53

26:53

In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, director of breast surgery, Robert Wood Johnson (RWJ), Barnabas Health, director of women’s oncologic health, RWJ Barnabas Health and Rutgers Cancer Institute, and head of breast surgery, Cooperman Barnabas Medical Center, discusses the current landscape of breast cancer treatment a…

1
S5 Ep6: Dizman’s Global Pursuit to Cancer Research and Understanding 19:05

8M ago19:05

19:05

In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.Targeted Talks による

1
S5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC 22:32

8M ago22:32

22:32

In this episode, Joshua K. Sabari, MD, discusses the FDA approval of amivantamab plus chemotherapy as a first-line treatment for patients with EGFR exon 20 insertion mutation-positive non-small cell lung cancer.Targeted Talks による

1
S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC 19:03

9M ago19:03

19:03

In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy.Targeted Talks による

1
S5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing 22:04

9M ago22:04

22:04

In season 5, episode 3 of Targeted Talks, Ben Derman, MD, assistant professor of medicine at the University of Chicago Medical Center, dissects the latest advancements in myeloma treatment, focusing on the role of ClonoSeq and minimal residual disease monitoring.Targeted Talks による

1
S5 Ep2: Beyond the First-Line: Economides on Advancing Therapies in RCC 20:06

10M ago20:06

20:06

In our 4th episode of Emerging Experts, Minas P. Economides, MD, assistant professor of medicine at NYU Langone Perlmutter Cancer Center, unveils the challenges and opportunities for renal cell carcinoma treatment, focusing on the lack of therapies available in the second-line setting.Targeted Talks による

1
S5 Ep1: A Deep Dive Into the Evolving Landscape of Prostate Cancer 23:52

10M ago23:52

23:52

In season 5, episode 1 of Targeted Talks, Badrinath Konety, MD, president of the Allina Health Cancer Institute and the chief academic officer for Allina Health, delves into the critical topic of prostate cancer screening, particularly for men within a community setting, and discusses some of the recent advancements in the prostate cancer space.…

1
S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care 15:49

11M ago15:49

15:49

In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings from the phase 3 TROPION-Lung01 study of datopotamab deruxtecan for the treatment of patients with advanced or metastatic non–small cell lung cancer.…

1
Target Talks: Building Trust and Impact with Adrian Jones 28:26

12M ago28:26

28:26

In this episode of Target Talks, Sarah Bryars sits down with Adrian Jones, Group Head of PR at the Benefact Group to discuss the role of PR in delivering their organisation’s purpose. Adrian begins by introducing listeners to the unique set-up of the Benefact Group and how it has evolved since its beginnings 135 years ago, to insure some of today’s…

1
S4 Ep19: Navigating the Landscape of Immunotherapy Toxicities 15:57

12M ago15:57

15:57

In our third episode of Emerging Experts, host Jordyn Sava is joined by Matthew Hadfield, DO, a third-year hematology/oncology fellow at Brown University, to discuss his interest and research in immunotherapy toxicities.Targeted Talks による

1
Target Talks: Taking Purposeful Action with Josephine Osborne 17:26

12M ago17:26

17:26

In this episode of Target Talks, Sam Kandiyali is joined by Josephine Osborne, Senior Project Manager at Specsavers. Jo begins by talking about Specsavers’ work in improving lives through better sight and hearing – the organisation’s purpose. She introduces listeners to Specsavers Homelessness programme which focuses on making eye and hearing care …

1
Delivering Purposeful Visual Communications 47:31

12M ago47:31

47:31

In this episode of Target Talks, Sarah Bryars and Sam Kandiyali are joined by Spencer McPherson, Chief Creative Officer of Still Moving, a creative agency who produce dynamic and engaging photography and film for brands around the world. Spencer begins (and ends) this episode by sharing stories of some of the many famous faces he has photographed, …

1
S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC 9:24

1y ago9:24

9:24

In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal cancer.Targeted Talks による

1
Target Talks: Creating Positive Change with Simone Hindmarch 34:38

1y ago34:38

34:38

On this episode of Target Talks, Sarah Bryars is joined by Simone Hindmarch, Co-founder and Managing Director of Commercial. Simone begins by telling us how, back in 2006, an invite to a client’s screening of An Inconvenient Truth became an ‘epiphany moment’ for her and kickstarted Commercial’s sustainability journey. Sarah and Simone discuss the i…

1
Target Talks: The Power of Social Media with Luan Wise 28:34

1y ago28:34

28:34

On this episode of Target Talks, Sarah Bryars and Sam Kandiyali sit down with Luan Wise, social media consultant and founder of The Lighthouse. As Luan tells us, she wasn’t one of social media’s first adopters– in fact, she was adamant that it wouldn’t take off... but that was back in 2007. She shares how she made the leap from account manager at a…

1
S4 Ep17: Bridging Science and Compassion in Cancer Care 20:24

1y ago20:24

20:24

In this episode of Emerging Experts, host Jordyn Sava is joined by Hemali Batra-Sharma, MD, fellow, Hematology/Oncology, University of California San Diego (UCSD) Medical Center, UCSD Health, to discuss insights into her passion for oncology and some of the experiences that have helped to shape her career.…

1
Target Talks: The Pillars of Purpose with Frank Nigriello 28:11

1y ago28:11

28:11

On the first episode of Target Talks, Sam Kandiyali is joined by Frank Nigriello, Director of Corporate Affairs at Unipart Group. Frank begins by sharing what purpose means to him in his role at Unipart, and the part that purpose plays in decision-making. Sam and Frank chat about the Pillars of Purpose model, and how PR can help businesses to build…

1
Target Talks: Purposeful PR Trailer 1:32

1y ago1:32

1:32

If you’re thinking about how you and your organisation can be a force for good, this podcast is a must listen. The six-episode series, brought to you by Target, an award-winning UK communications agency, explores different aspects of purposeful PR and communications. From building communities, to storytelling, engaging stakeholders and influencing …

1
S4 Ep16: Tailoring Treatments to Better Outcomes in Liver Cancer 25:35

1y ago25:35

25:35

In season 4, episode 16 of Targeted Talks, Susanne G. Warner, MD, hepatobiliary and pancreas surgeon at the Mayo Clinic in Rochester, Minnesota, discusses the importance of tailoring treatments for patients with liver cancer, taking into account the staging of the cancer.Targeted Talks による

1
S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field 11:50

1y ago11:50

11:50

In our first episode of Emerging Experts, Aakash Desai, MD, MPH, discusses his journey through the oncology field by reminiscing on the encouraging guidance of his mentors, personal research goals, and his experiences thus far as an oncologist.Targeted Talks による

1
S4 Ep14: First Real-World Data on Second-Generation AR Inhibitor Use in nmCRPC 7:52

1y ago7:52

7:52

Alicia Morgan, MD, MPH on real-world data from the DEAR study.Targeted Talks による

1
S4 Ep13: Strategies for Neoadjuvant NSCLC Treatment 10:04

1y ago10:04

10:04

An interview with Benny Weskler, MBA, MD, FACS, FACCP of Allegheny Health Network.Targeted Talks による

1
S4 Ep12: Lessons from Real-World Cases of Small Cell Lung Cancer 16:53

1+ y ago16:53

16:53

Federico Albrecht, MD discusses 2 small cell lung cancer cases.Targeted Talks による

1
S4 Ep11: Social Determinants of Health Impacting Oncology Today 10:16

1+ y ago10:16

10:16

Targeted Talks による

1
S4 Ep10: Recommendations for Treating Central Nervous Systems Cancers 8:19

1+ y ago8:19

8:19

Craig Horbinski, MD, PhD, unpacks the NCCN Clinical Practice Guidelines for central nervous system tumors.Targeted Talks による

1
S4 Ep9: Mitigating Cardiotoxicity Resulting from Immune Checkpoint Inhibitor Therapy 12:43

1+ y ago12:43

12:43

In season 4, episode 9 of Targeted Talks, Kerry Reynolds, MD of Massachusetts General Hospital discusses the occurrence of myocarditis in patients with cancer treated with immune checkpoint inhibitors.Targeted Talks による

1
S4 Ep8: Pushing Forward With Molecularly-Driven Precision Medicine in Endometrial Cancer 21:12

1+ y ago21:12

21:12

An interview with Ruchi Garg, MD of City of Hope.Targeted Talks による

1
S4 Ep7: Exciting Activity in Chronic Lymphocytic Leukemia 8:05

1+ y ago8:05

8:05

Targeted Talks による

1
S4 Ep6: Anticipating Novel Treatments for the RAI-Refractory DTC Armamentarium 8:32

1+ y ago8:32

8:32

An interview with Warren Swegal, MD.Targeted Talks による

1
S4 Ep5: Advancing the Treatment of Alveolar Soft Part Sarcoma 13:16

1+ y ago13:16

13:16

An interview with Alice P. Chen, MD of the National Cancer Institute.Targeted Talks による

1
S4 Ep4: Understanding and Treating Mucosal Melanoma 11:44

1+ y ago11:44

11:44

Richard D. Carvajal, MD, discusses mucosal melanoma and treatment options for the disease.Targeted Talks による

1
S4 Ep3: Hitting New Targets in Metastatic Prostate Cancer 12:31

1+ y ago12:31

12:31

In season 4, episode 3 of Targeted Talks, Pedro Barata, MD, MSc, discusses the present and future of prostate cancer precision medicine.Targeted Talks による

1
S4 Ep2: The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment 9:48

1+ y ago9:48

9:48

A talk with Sara A. Hurvitz, MD about advances in the HER2-positive breast cancer space.Targeted Talks による

1
S4 Ep1: Unpacking the Latest Research in Gastrointestinal Cancers 17:36

2y ago17:36

17:36

In season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, of Dana-Farber Cancer Institute discuses new studies in gastrointestinal malignancies.Targeted Talks による

1
S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment 21:04

2y ago21:04

21:04

In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America Atlanta, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.Targeted Talks による

1
S3 Ep9: Special Episode: Managing Cardiotoxicity from ICI Therapy in Patients with Cancer 17:45

2y ago17:45

17:45

In season 3, episode 9 of Targeted Talks, Mohammed Salhab, MD, Chris Fine, MD, FACC, cardiologist at National Jewish Health, have a special discussion about cardiotoxicity from immune checkpoint inhibitor therapy in patients with cancer.Targeted Talks による

聞く価値のあるポッドキャスト

ポッドキャスト Targeted Talks

聞く価値のあるポッドキャスト

クイックリファレンスガイド